World allergy organization guidelines for the assessment and management of anaphylaxis

World Allergy Organization Journal

Volumn 4, Issue 2, 2011, Pages 13-37

  Simons, F Estelle R ^a   Ardusso, Ledit R F ^b   Bilò, M Beatrice ^c   El Gamal, Yehia M ^d   Ledford, Dennis K ^e   Ring, Johannes ^f   Sanchez Borges, Mario ^g   Senna, Gian Enrico ^h   Sheikh, Aziz ⁱ   Thong, Bernard ^j  

^a UNIVERSITY OF MANITOBA   (Canada)

^b FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^c OSPEDALI RIUNITI   (Italy)

^d AIN SHAMS UNIVERSITY   (Egypt)

^e UNIVERSITY OF SOUTH FLORIDA   (United States)

^f TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^g Centro Medico Docente La Trinidad   (Venezuela)

^h Verona General Hospital   (Italy)

ⁱ UNIVERSITY OF EDINBURGH   (United Kingdom)

^j TAN TOCK SENG HOSPITAL   (Singapore)

more..

Author keywords

Anaphylaxis; Antihistamines; Clinical diagnosis; Epinephrine (adrenaline); Glucocorticoids; Risk factors

Indexed keywords

ADRENALIN; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CARBOPLATIN; CETIRIZINE; CETUXIMAB; CHLORPHENIRAMINE; DIPHENHYDRAMINE; DOXORUBICIN; GLUCAGON; HYDROCORTISONE; INFLIXIMAB; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; OMALIZUMAB; PENICILLIN G; PREDNISOLONE; PREDNISONE; RANITIDINE; RITUXIMAB; SALBUTAMOL;

ANAPHYLAXIS; ANXIETY; ARTICLE; CLINICAL FEATURE; COGNITIVE DEFECT; DIZZINESS; DROWSINESS; EMERGENCY CARE; FLUID RESUSCITATION; HEADACHE; HEALTH CARE FACILITY; HEALTH CARE ORGANIZATION; HEART PALPITATION; HOSPITAL DISCHARGE; HUMAN; IMMUNOMODULATION; LABORATORY TEST; NERVOUSNESS; OXYGEN SUPPLY; PALLOR; PATIENT CARE; PATIENT POSITIONING; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESUSCITATION; RISK FACTOR; SIDE EFFECT; SOMNOLENCE; TACHYCARDIA; TREMOR; VITAL SIGN; WORLD HEALTH ORGANIZATION;

EID: 79954432935     PISSN: 19394551     EISSN: None     Source Type: Journal    
DOI: 10.1097/WOX.0b013e318211496c     Document Type: Article

References (150)

1. Johansson SGO, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, et al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol. 2004;113:832- 836. (Pubitemid 38608590)
2. Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF Jr, Bock SA, Branum A, et al. Second symposium on the definition and management of anaphylaxis: summary report: Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network Symposium. J Allergy Clin Immunol. 2006;117:391-397. (Pubitemid 43190153)
3. Simons FER, for the World Allergy Organization. World Allergy Organization survey on global availability of essentials for the assessment and management of anaphylaxis by allergy/immunology specialists in healthcare settings. Ann Allergy Asthma Immunol. 2010;104: 405-412.
4. Lieberman P, Camargo CA Jr, Bohlke K, Jick H, Miller RL, Sheikh A, et al. Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group. Ann Allergy Asthma Immunol. 2006;97:596-602. (Pubitemid 44851454)
5. Decker WW, Campbell RL, Manivannan V, Luke A, St Sauver JL, Weaver A, et al. The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project. J Allergy Clin Immunol. 2008;122:1161-1165.
6. Sheikh A, Hippisley-Cox J, Newton J, Fenty J. Trends in national incidence, lifetime prevalence and adrenaline prescribing for anaphylaxis in England. J R Soc Med. 2008;101:139 -143. (Pubitemid 351570668)
7. Liew WK, Williamson E, Tang MLK. Anaphylaxis fatalities and admissions in Australia. J Allergy Clin Immunol. 2009;123:434-442.
8. Bock SA, Munoz-Furlong A, Sampson HA. Further fatalities caused by anaphylactic reactions to food, 2001-2006. J Allergy Clin Immunol. 2007;119:1016 -1018. (Pubitemid 46527814)
9. Pumphrey RSH, Gowland MH. Further fatal allergic reactions to food in the United Kingdom, 1999-2006. J Allergy Clin Immunol. 2007; 119:1018 -1019. (Pubitemid 46527829)
10. Greenberger PA, Rotskoff BD, Lifschultz B. Fatal anaphylaxis: postmortem findings and associated comorbid diseases. Ann Allergy Asthma Immunol. 2007;98:252-257. (Pubitemid 46417570)
11. Shen Y, Li L, Grant J, Rubio A, Zhao Z, Zhang X, et al. Anaphylactic deaths in Maryland (United States) and Shanghai (China): a review of forensic autopsy cases from 2004 to 2006. Forensic Sci Int. 2009;186: 1-5.
12. Yilmaz R, Yuksekbas O, Erkol Z, Bulut ER, Arslan MN. Postmortem findings after anaphylactic reactions to drugs in Turkey. Am J Forensic Med Pathol. 2009;30:346 -349.
13. Pumphrey RSH. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy. 2000;30:1144 -1150. (Pubitemid 30619768)
14. Sheikh A, Shehata YA, Brown SGA, Simons FER. Adrenaline for the treatment of anaphylaxis: Cochrane systematic review. Allergy. 2009; 64:204 -212.
15. 1- antihistamines for the treatment of anaphylaxis: Cochrane systematic review. Allergy. 2007;62:830-837. (Pubitemid 47037864)
16. Choo KJL, Simons FER, Sheikh A. Glucocorticoids for the treatment of anaphylaxis. Cochrane Database Syst Rev. 2009;1:CD007596.
17. Bousquet J, Clark TJH, Hurd S, Khaltaev N, Lenfant C, O'Byrne P, et al. GINA guidelines on asthma and beyond. Allergy. 2007;62: 102-112. (Pubitemid 46091634)
18. National Institutes of Health, National Heart Lung and Blood Institute, National Asthma Education and Prevention Program. Expert Panel Report 3: guidelines for the diagnosis and management of asthma, August 2007. NIH publication no. 07-4051. available at http://www.nhlbi.nih.gov/guidelines/ asthma, Accessed November 23, 2010.
19. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA2LEN, and AllerGen). Allergy. 2008;63(Suppl. 86):8-160. (Pubitemid 351357811)
20. Simons FER. Pharmacologic treatment of anaphylaxis: can the evidence base be strengthened? Curr Opin Allergy Clin Immunol. 2010; 10:384 -393.
21. Alrasbi M, Sheikh A. Comparison of international guidelines for the emergency medical management of anaphylaxis. Allergy. 2007;62: 838-841. (Pubitemid 47037863)
22. Soar J, Pumphrey R, Cant A, Clarke S, Corbett A, Dawson P, et al. Emergency treatment of anaphylactic reactions: guidelines for healthcare providers. Resuscitation. 2008;77:157- 69.
23. Brown SGA, Mullins RJ, Gold MS. Anaphylaxis: diagnosis and management. Med J Aust. 2006;185:283-289.
24. Lieberman P, Nicklas RA, Oppenheimer J, Kemp SF, Lang DM, et al. The diagnosis and management of anaphylaxis practice parameter: 2010 Update. J Allergy Clin Immunol. 2010;126:477- 480.
25. Muraro A, Roberts G, Clark A, Eigenmann PA, Halken S, Lack G, et al. The management of anaphylaxis in childhood: position paper of the European Academy of Allergology and Clinical Immunology. Allergy. 2007;62:857- 871. (Pubitemid 47037857)
26. Endo T, Shinozawa Y. Practice guidelines 2005: management of anaphylaxis. Nippon Naika Gakkai Zasshi. 2006;95:2463-2468.
27. Comite de Alergia e Inmunologia. Normativa para el tratamiento del choque anafilactico. Arch Arg Pediatr. 1998;96:272.
28. Malling H-J, Hansen KS. Anafylaksi [Anaphylaxis]. Ugeskr Laeger. 2005;167:664-666.
29. Bernd LAG, Sole D, Pastorino AC, do Prado EA, Castro FFM, Rizzo MCV, et al. Anafilaxia: guia pratico para o manejo. Rev Bras Alerg Imunopatol. 2006;29:283-291.
30. Shekelle PG, Woolf SH, Eccles M, Grimshaw J. Clinical guidelines: developing guidelines. BMJ. 1999;318:593-596.
31. Sampson HA, Munoz-Furlong A, Bock SA, Schmitt C, Bass R, Chowdhury BA, et al. Symposium on the definition and management of anaphylaxis: summary report. J Allergy Clin Immunol. 2005;115:584- 591. (Pubitemid 40341714)
32. Simons FER. Anaphylaxis. J Allergy Clin Immunol. 2010;125:S161- S181.
33. Cox L, Larenas-Linnemann D, Lockey RF, Passalacqua G. Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System. J Allergy Clin Immunol. 2010;125:569 -574.
34. Simons FER. Anaphylaxis in infants: can recognition and management be improved? J Allergy Clin Immunol. 2007;120:537-540. (Pubitemid 47334840)
35. Alves B, Sheikh A. Age specific aetiology of anaphylaxis. Arch Dis Child. 2001;85:348.
36. Chaudhuri K, Gonzales J, Jesurun CA, Ambat MT, Mandal-Chaudhuri S. Anaphylactic shock in pregnancy: a case study and review of the literature. Int J Obstet Anesth. 2008;17:350 -357.
37. Gonzalez-Perez A, Aponte Z, Vidaurre CF, Rodriguez LAG. Anaphylaxis epidemiology in patients with and patients without asthma: a United Kingdom database review. J Allergy Clin Immunol. 2010;125: 1098-1104.
38. Iribarren C, Tolstykh IV, Miller MK, Eisner MD. Asthma and the prospective risk of anaphylactic shock and other allergy diagnoses in a large integrated health care delivery system. Ann Allergy Asthma Immunol. 2010;104:371-377.
39. Triggiani M, Patella V, Staiano RI, Granata F, Marone G. Allergy and the cardiovascular system. Clin Exp Immunol. 2008;153 (Suppl 1):7-11. (Pubitemid 352020376)
40. Lieberman P. Use of epinephrine in the treatment of anaphylaxis. Curr Opin Allergy Clin Immunol. 2003;3:313-318. (Pubitemid 37010889)
41. Mueller UR. Cardiovascular disease and anaphylaxis. Curr Opin Allergy Clin Immunol. 2007;7:337-341. (Pubitemid 47052022)
42. Brockow K, Jofer C, Behrendt H, Ring J. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy. 2008;63:226 -232.
43. Bonadonna P, Perbellini O, Passalacqua G, Caruso B, Colarossi S, Dal Fior D, et al. Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels. J Allergy Clin Immunol. 2009;123:680-686.
44. Metcalfe DD, Schwartz LB. Assessing anaphylactic risk? Consider mast cell clonality. J Allergy Clin Immunol. 2009;123:687- 688.
45. Summers CW, Pumphrey RS, Woods CN, McDowell G, Pemberton PW, Arkwright PD. Factors predicting anaphylaxis to peanuts and tree nuts in patients referred to a specialist center. J Allergy Clin Immunol. 2008;121:632- 638.
46. TenBrook JA Jr, Wolf MP, Hoffman SN, Rosenwasser LJ, Konstam MA, Salem DN, et al. Should beta-blockers be given to patients with heart disease and peanut-induced anaphylaxis? A decision analysis. J Allergy Clin Immunol. 2004;113:977-982. (Pubitemid 38608610)
47. Rueff F, Przybilla B, Bilo MB, Muller U, Scheipl F, Aberer W, et al. Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity. J Allergy Clin Immunol. 2009;124:1047-10454.
48. Caviglia AG, Passalacqua G, Senna G. Risk of severe anaphylaxis for patients with Hymenoptera venom allergy: are angiotensin-receptor blockers comparable to angiotensin-converting enzyme inhibitors? J Allergy Clin Immunol. 2010;125:1171.
49. Hershko AY, Dranitzki Z, Ulmanski R, Levi-Schaffer F, Naparstek Y. Constitutive hyperhistaminaemia: a possible mechanism for recurrent anaphylaxis. Scand J Clin Lab Invest. 2001;61:449-452. (Pubitemid 32900432)
50. Schwartz LB. Diagnostic value of tryptase in anaphylaxis and mastocytosis. Immunol Allergy Clin North Am. 2006;26:451- 463. (Pubitemid 44247540)
51. Komarow HD, Hu Z, Brittain E, Uzzaman A, Gaskins D, Metcalfe DD. Serum tryptase levels in atopic and nonatopic children. J Allergy Clin Immunol. 2009;124:845- 848.
52. Vadas P, Gold M, Perelman B, Liss G, Lack G, Blyth T, et al. Platelet-activating factor, PAF acetylhydrolase and severe anaphylaxis. N Engl J Med. 2008;358:28 -35.
53. Robson-Ansley P, Du Toit G. Pathophysiology, diagnosis and management of exercise-induced anaphylaxis. Curr Opin Allergy Clin Immunol. 2010;10:312-317.
54. Baek C-H, Bae Y-J, Cho YS, Moon H-B, Kim T-B. Food-dependent exercise-induced anaphylaxis in the celery-mugwort-birch-spice syndrome. Allergy. 2010;65:792-793.
55. Sanchez-Borges M, Iraola V, Fernandez-Caldas E, Capriles-Hulett A, Caballero-Fonseca F. Dust mite ingestion-associated, exercise-induced anaphylaxis. J Allergy Clin Immunol. 2007;120:714 -716. (Pubitemid 47320738)
56. Matsuo H, Kaneko S, Tsujino Y, Honda S, Kohno K, Takahashi H, et al. Effects of non-steroidal anti-inflammatory drugs (NSAIDs) on serum allergen levels after wheat ingestion. J Dermatol Sci. 2009;53: 241-243.
57. Ring J, Grosber M, Mohrenschlager M, Brockow K. Anaphylaxis: acute treatment and management. Chem Immunol Allergy. 2010;95: 201-210.
58. Boyce JA, Assa'ad A, Burks AW, Jones SM, Sampson HA, Wood RA, et al. Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-sponsored Expert Panel Report. J Allergy Clin Immunol. 2010;126:1105-1118.
59. Sicherer SH, Sampson HA. Food allergy. J Allergy Clin Immunol. 2010;125:S116 -S125.
60. Asero R, Antonicelli L, Arena A, Bommarito L, Caruso B, Colombo G, et al. Causes of food-induced anaphylaxis in Italian adults: a multicentre study. Int Arch Allergy Immunol. 2009;150:271-277.
61. Shek LPC, Lee BW. Food allergy in Asia. Curr Opin Allergy Clin Immunol. 2006;6:197-201. (Pubitemid 44510203)
62. Thong BY, Cheng YK, Leong KP, Tang CY, Chng HH. Anaphylaxis in adults referred to a clinical immunology/allergy centre in Singapore. Singapore Med J. 2005;46:529 -534. (Pubitemid 41406518)
63. Sanchez-Borges M, Suarez-Chacon R, Capriles-Hulett A, Caballero- Fonseca F. An update on oral anaphylaxis from mite ingestion. Ann Allergy Asthma Immunol. 2005;94:216 -221.
64. Ji K-M, Zhan Z-K, Chen J-J, Liu Z-G. Anaphylactic shock caused by silkworm pupa consumption in China. Allergy. 2008;63:1407-1408.
65. Polimeno L, Loiacono M, Pesetti B, Mallamaci R, Mastrodonato M, Azzarone A, et al. Anisakiasis, an underestimated infection: effect on intestinal permeability of Anisakis simplex-sensitized patients. Foodborne Pathog Dis. 2010;7:809-814.
66. Ebisawa M. Management of food allergy in Japan "food allergy management guideline 2008 (revision from 2005)" and "guidelines for the treatment of allergic diseases in schools." Allergol Int. 2009;58: 475-483.
67. Commins SP, Satinover SM, Hosen J, Mozena J, Borish L, Lewis BD, et al. Delayed anaphylaxis, angioedema, or urticaria after consumption of red meat in patients with IgE antibodies specific for galactose-alpha- 1, 3-galactose. J Allergy Clin Immunol. 2009;123:426-433.
68. Bilo MB, Bonifazi F. The natural history and epidemiology of insect venom allergy: clinical implications. Clin Exp Allergy. 2009;39:1467- 1476.
69. Muller UR. Insect venoms. Chem Immunol Allergy. 2010;95:141-156.
70. Shek LPC, Ngiam NSP, Lee BW. Ant allergy in Asia and Australia. Curr Opin Allergy Clin Immunol. 2004;4:325-328. (Pubitemid 39006849)
71. Tankersley MS. The stinging impact of the imported fire ant. Curr Opin Allergy Clin Immunol. 2008;8:354 -359.
72. Khan DA, Solensky R, et al. Drug allergy: an updated practice parameter. J Allergy Clin Immunol. 2010;125:S126 -S137.
73. Mirakian R, Ewan PW, Durham SR, Youlten LJF, Dugue P, Friedmann PS, et al. BSACI guidelines for the management of drug allergy. Clin Exp Allergy. 2009;39:43- 61.
74. Berges-Gimeno MP, Martin-Lazaro J. Allergic reactions to nonsteroidal anti-inflammatory drugs: is newer better? Curr Allergy Asthma Rep. 2007;7:35- 40. (Pubitemid 46647025)
75. Limb SL, Starke PR, Lee CE, Chowdhury BA. Delayed onset and protracted progression of anaphylaxis after omalizumab administration in patients with asthma. J Allergy Clin Immunol. 2007;120: 1378 -1381. (Pubitemid 350216608)
76. Castells M. Rapid desensitization for hypersensitivity reactions to medications. Immunol Allergy Clin North Am. 2009;29:585- 606.
77. Castells MC, Tennant NM, Sloane DE, Hsu FI, Barrett NA, Hong DI, et al. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases. J Allergy Clin Immunol. 2008; 122:574 -580.
78. Kishimoto TK, Viswanathan K, Ganguly T, Elankumaran S, Smith S, Pelzer K, et al. Contaminated heparin associated with adverse clinical events and activation of the contact system. N Engl J Med. 2008;358: 2457-2467. (Pubitemid 351793019)
79. Ji K, Chen J, Li M, Liu Z, Xia L, Wang C, et al. Comments on serious anaphylaxis caused by nine Chinese herbal injections used to treat common colds and upper respiratory tract infections. Regul Toxicol Pharmacol. 2009;55:134 -138.
80. Brockow K, Ring J. Classification and pathophysiology of radiocontrast media hypersensitivity. Chem Immunol Allergy. 2010;95:157- 169.
81. Thong BY, Yeow-Chan. Anaphylaxis during surgical and interventional procedures. Ann Allergy Asthma Immunol. 2004;92:619-628. (Pubitemid 39243151)
82. Chacko T, Ledford D. Peri-anesthetic anaphylaxis. Immunol Allergy Clin North Am. 2007;27:213-230. (Pubitemid 46691337)
83. Bernstein IL, Li JT, Bernstein DI, Hamilton R, Spector SL, Tan R, et al. Allergy diagnostic testing: an updated practice parameter. Ann Allergy Asthma Immunol. 2008;100:S1-S148. (Pubitemid 351409337)
84. Rezvani M, Bernstein DI. Anaphylactic reactions during immunotherapy. Immunol Allergy Clin North Am. 2007;27:295-307. (Pubitemid 46686989)
85. Kelso JM, Li JT, Nicklas RA, Bernstein DI, Blessing-Moore J, Cox L, et al. Adverse reactions to vaccines. Ann Allergy Asthma Immunol. 2009;103:S1-S14.
86. Basagana M, Bartolome B, Pastor C, Torres F, Alonso R, Vivanco F, et al. Allergy to human seminal fluid: cross-reactivity with dog dander. J Allergy Clin Immunol. 2008;121:233-239.
87. Greenberger PA. Idiopathic anaphylaxis. Immunol Allergy Clin North Am. 2007;27:273-293. (Pubitemid 46686988)
88. Ridella M, Bagdure S, Nugent K, Cevik C. Kounis syndrome following beta-lactam antibiotic use: review of literature. Inflamm Allergy Drug Targets. 2009;8:11-16.
89. Biteker M, Duran NE, Biteker FS, Civan HA, Kaya H, Gokdeniz T, et al. Allergic myocardial infarction in childhood: Kounis syndrome. Eur J Pediatr. 2010;169:27-29.
90. Simons FER, Frew AJ, Ansotegui IJ, Bochner BS, Finkelman F, Golden DBK, et al. Risk assessment in anaphylaxis: current and future approaches. J Allergy Clin Immunol. 2007;120:S2-S24. (Pubitemid 46977436)
91. Druey KM, Greipp PR. Narrative review: the systemic capillary leak syndrome. Ann Intern Med. 2010;153:90 -98.
92. Zuraw BL. Clinical practice. Hereditary angioedema. N Engl J Med. 2008;359:1027-1036.
93. Pumphrey RSH. Fatal posture in anaphylactic shock. J Allergy Clin Immunol. 2003;112:451- 452.
94. Field JM, Hazinski MF, Sayre MR, Chameides L, Schexnayder SM, Hemphill R, et al. Part 1: Executive summary: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2010;122:S640 -S656.
95. Svensson L, Bohm K, Castren M, Petersson H, Engerstrom L, Herlitz J, et al. Compression-only CPR or standard CPR in out-of-hospital cardiac arrest. N Engl J Med. 2010;363:434-442.
96. Oswalt ML, Kemp SF. Anaphylaxis: office management and prevention. Immunol Allergy Clin North Am. 2007;27:177-191. (Pubitemid 46686985)
97. Simons KJ, Simons FER. Epinephrine and its use in anaphylaxis: current issues. Curr Opin Allergy Clin Immunol. 2010;10:354 -361.
98. McLean-Tooke APC, Bethune CA, Fay AC, Spickett GP. Adrenaline in the treatment of anaphylaxis: what is the evidence? BMJ. 2003;327: 1332-1335. (Pubitemid 37510459)
99. Kemp SF, Lockey RF, Simons FER. Epinephrine: the drug of choice for anaphylaxis. A statement of the World Allergy Organization. Allergy. 2008;63:1061-1070.
100. Sackett DL, Rosenberg WM, Gray JA, et al. Evidence-based medicine: what it is and what it isn't. BMJ. 1996;312:71-72.
101. Simons FER. Lack of worldwide availability of epinephrine autoinjectors for outpatients at risk of anaphylaxis. Ann Allergy Asthma Immunol. 2005;94:534 -538. (Pubitemid 40712775)
102. Simons FER, for the World Allergy Organization. Epinephrine autoinjectors: first-aid treatment still out of reach for many at risk of anaphylaxis in the community. Ann Allergy Asthma Immunol. 2009; 102:403- 409.
103. Smith PL, Kagey-Sobotka A, Bleecker ER, Traystman R, Kaplan AP, Gralnick H, et al. Physiologic manifestations of human anaphylaxis. J Clin Invest. 1980;66:1072-1080. (Pubitemid 11233809)
104. Brown SGA, Blackman KE, Stenlake V, Heddle RJ. Insect sting anaphylaxis; prospective evaluation of treatment with intravenous adrenaline and volume resuscitation. Emerg Med J. 2004;21:149 -154. (Pubitemid 38344625)
105. Scranton SE, Gonzalez EG, Waibel KH. Incidence and characteristics of biphasic reactions after allergen immunotherapy. J Allergy Clin Immunol. 2009;123:493- 498.
106. Confino-Cohen R, Goldberg A. Allergen immunotherapy-induced biphasic systemic reactions: incidence, characteristics, and outcome: a prospective study. Ann Allergy Asthma Immunol. 2010;104: 73-78.
107. Bautista E, Simons FER, Simons KJ, Becker AB, Duke K, Millett M, et al. Epinephrine fails to hasten hemodynamic recovery in fullydeveloped anaphylactic shock. Int Arch Allergy Immunol. 2002;128: 151-164. (Pubitemid 34639024)
108. Rawas-Qalaji M, Simons FER, Collins D, Simons KJ. Long-term stability of epinephrine dispensed in unsealed syringes for the first-aid treatment of anaphylaxis. Ann Allergy Asthma Immunol. 2009;102: 500-503.
109. Manivannan V, Campbell RL, Bellolio MF, Stead LG, Li JTC, Decker WW. Factors associated with repeated use of epinephrine for the treatment of anaphylaxis. Ann Allergy Asthma Immunol. 2009;103: 395-400.
110. Rudders SA, Banerji A, Katzman DP, Clark S, Camargo CA Jr. Multiple epinephrine doses for stinging insect hypersensitivity reactions treated in the emergency department. Ann Allergy Asthma Immunol. 2010;105:85-93.
111. Gaeta TJ, Clark S, Pelletier AJ, Camargo CA. National study of US emergency department visits for acute allergic reactions, 1993 to 2004. Ann Allergy Asthma Immunol. 2007;98:360 -365. (Pubitemid 46582128)
112. Simons FER, Clark S, Camargo CA. Anaphylaxis in the community: learning from the survivors. J Allergy Clin Immunol. 2009;124:301- 306.
113. Simons FER, Edwards ES, Read EJ Jr, Clark S, Liebelt EL. Voluntarily reported unintentional injections from epinephrine auto-injectors. J Allergy Clin Immunol. 2010;125:419-423.
114. Ben-Shoshan M, Kagan R, Primeau MN, Alizadehfar R, Verreault N, Yu JW, et al. Availability of the epinephrine autoinjector at school in children with peanut allergy. Ann Allergy Asthma Immunol. 2008;100: 570-575. (Pubitemid 351829856)
115. Campbell RL, Luke A, Weaver AL, St Sauver JL, Bergstralh EJ, Li JT, et al. Prescriptions for self-injectable epinephrine and follow-up referral in emergency department patients presenting with anaphylaxis. Ann Allergy Asthma Immunol. 2008;101:631-636.
116. Kanwar M, Irvin CB, Frank JJ, Weber K, Rosman H. Confusion about epinephrine dosing leading to iatrogenic overdose: a life-threatening problem with a potential solution. Ann Emerg Med. 2010;55:341-344.
117. Tole JW, Lieberman P. Biphasic anaphylaxis: review of incidence, clinical predictors, and observation recommendations. Immunol Allergy Clin North Am. 2007;27:309 -326. (Pubitemid 46686990)
118. Ellis AK, Day JH. Incidence and characteristics of biphasic anaphylaxis: a prospective evaluation of 103 patients. Ann Allergy Asthma Immunol. 2007;98:64-69. (Pubitemid 46106160)
119. Mehr S, Liew WK, Tey D, Tang MLK. Clinical predictors for biphasic reactions in children presenting with anaphylaxis. Clin Exp Allergy. 2009;39:1390 -1396.
120. Smit DV, Cameron PA, Rainer TH. Anaphylaxis presentations to an emergency department in Hong Kong: incidence and predictors of biphasic reactions. J Emerg Med. 2005;28:381-388. (Pubitemid 40523684)
121. 1-antihistamines. N Engl J Med. 2004;351: 2203-2217.
122. Runge JW, Martinez JC, Caraveti EM, Williamson SG, Hartsell SC. Histamine antagonists in the treatment of acute allergic reactions. Ann Emerg Med. 1992;21:237-242.
123. 2 antagonists. Ann Emerg Med. 2000;36:462- 468.
124. Jones DH, Romero FA, Casale TB. Time-dependent inhibition of histamine-induced cutaneous responses by oral and intramuscular diphenhydramine and oral fexofenadine. Ann Allergy Asthma Immunol. 2008;100:452- 456. (Pubitemid 351668781)
125. Rowe BH, Spooner C, Ducharme F, Bretzlaff J, Bota G. Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database Syst Rev. 2008;4:CD002178.
126. Krishnan JA, Davis SQ, Naureckas ET, Gibson P, Rowe BH. An umbrella review: corticosteroid therapy for adults with acute asthma. Am J Med. 2009;122:977-991.
127. Foti C, Cassano N, Panebianco R, Calogiuri GF, Vena GA. Hypersensitivity reaction to ranitidine: description of a case and review of the literature. Immunopharmacol Immunotoxicol. 2009;31:414-416.
128. Mullner M, Urbanek B, Havel C, Losert H, Waechter F, Gamper G. Vasopressors for shock. Cochrane Database Syst Rev. 2004;3: CD003709.
129. Ellender TJ, Skinner JC. The use of vasopressors and inotropes in the emergency medical treatment of shock. Emerg Med Clin North Am. 2008;26:759 -786. (Pubitemid 352004096)
130. Gueugniaud PY, David JS, Chanzy E, Hubert H, Dubien PY, Mauriaucourt P, et al. Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation. N Engl J Med. 2008;359:21-30. (Pubitemid 351931093)
131. Thomas M, Crawford I. Best evidence topic report. Glucagon infusion in refractory anaphylactic shock in patients on beta-blockers. Emerg Med J. 2005;22:272-273. (Pubitemid 40520707)
132. Simons FER. Anaphylaxis, killer allergy: long-term management in the community. J Allergy Clin Immunol. 2006;117:367-377. (Pubitemid 43190151)
133. Lieberman P, Decker W, Camargo CA Jr, O'Connor R, Oppenheimer J, Simons FE. SAFE: a multidisciplinary approach to anaphylaxis education in the emergency department. Ann Allergy Asthma Immunol. 2007;98:519 -523. (Pubitemid 46933855)
134. Nurmatov U, Worth A, Sheikh A. Anaphylaxis management plans for the acute and long-term management of anaphylaxis: a systematic review. J Allergy Clin Immunol. 2008;122:353-361.
135. Moffitt JE, Golden DBK, Reisman RE, Lee R, Nicklas R, Freeman T, et al. Stinging insect hypersensitivity: a practice parameter update. J Allergy Clin Immunol. 2004;114:869-886. (Pubitemid 39330260)
136. Brown SGA, Wiese MD, Blackman KE, Heddle RJ. Ant venom immunotherapy: a double-blind, placebo-controlled, crossover trial. Lancet. 2003;361:1001-1006. (Pubitemid 36351369)
137. Golden DBK. Insect sting allergy and venom immunotherapy: a model and a mystery. J Allergy Clin Immunol. 2005;115:439-447. (Pubitemid 40341690)
138. Nowak-Wegrzyn A, Assa'ad AH, Bahna SL, Bock SA, Sicherer SH, Teuber SS. Work Group report: oral food challenge testing. J Allergy Clin Immunol. 2009;123:S365-S383.
139. Loibl M, Schwarz S, Ring J, Halle M, Brockow K. Definition of an exercise intensity threshold in a challenge test to diagnose fooddependent exercise-induced anaphylaxis. Allergy. 2009;64:1560 -1561.
140. Wanich N, Nowak-Wegrzyn A, Sampson HA, Shreffler WG. Allergen- specific basophil suppression associated with clinical tolerance in patients with milk allergy. J Allergy Clin Immunol. 2009;123: 789 -794.
141. Ott H, Baron JM, Heise R, Ocklenburg C, Stanzel S, Merk HF, et al. Clinical usefulness of microarray-based IgE detection in children with suspected food allergy. Allergy. 2008;63:1521-1528.
142. Boyano-Martinez T, Garcia-Ara C, Pedrosa M, Diaz-Pena JM, Quirce S. Accidental allergic reactions in children allergic to cow's milk proteins. J Allergy Clin Immunol. 2009;123:883- 888.
143. Pieretti MM, Chung D, Pacenza R, Slotkin T, Sicherer SH. Audit of manufactured products: use of allergen advisory labels and identification of labeling ambiguities. J Allergy Clin Immunol. 2009;124: 337-341.
144. Crotty MP, Taylor SL. Risks associated with foods having advisory milk labeling. J Allergy Clin Immunol. 2010;125:935-937.
145. King RM, Knibb RC, Hourihane JO'B. Impact of peanut allergy on quality of life, stress and anxiety in the family. Allergy. 2009;64:461-468.
146. Herbert LJ, Dahlquist LM. Perceived history of anaphylaxis and parental overprotection, autonomy, anxiety, and depression in food allergic young adults. J Clin Psychol Med Settings. 2008;15:261-269.
147. Skripak JM, Nash SD, Rowley H, Brereton NH, Oh S, Hamilton RG, et al. A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergy. J Allergy Clin Immunol. 2008;122:1154 -1160.
148. Narisety SD, Skripak JM, Steele P, Hamilton RG, Matsui EC, Burks AW, et al. Open-label maintenance after milk oral immunotherapy for IgEmediated cow's milk allergy. J Allergy Clin Immunol. 2009;124:610-612.
149. Warrier P, Casale TB. Omalizumab in idiopathic anaphylaxis. Ann Allergy Asthma Immunol. 2009;102:257-258.
150. Simons FER. Anaphylaxis: recent advances in assessment and treatment. J Allergy Clin Immunol. 2009;124:625- 636.